Liat Strep a Assay
FDA 510(k) K141338 · Iquum, Inc.
510(k) numberK141338
Submission
- Device name
- Liat Strep a Assay
- Applicant
- Iquum, Inc.
Marlborough, MA, US - Received
- May 21, 2014
- Decision date
- November 4, 2014
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- PGX – Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.2680
- Specialty
- Microbiology
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.
Other 510(k)s with product code PGX
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K260047 | cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas…PGX · Traditional | Roche Molecular Systems, Inc. | 08/28/2026SE |
| K260333 | LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab KitPGX · Dual Track | Diasorin Molecular, LLC | 06/15/2026SE |
| K201269 | Accula Strep A TestPGX · Dual Track | Mesa Biotech, Inc. | 11/09/2020SE |
| K183366 | GenePOC Strep APGX · Traditional | Genepoc, Inc. | 03/06/2019SE |
| K173653 | Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab KitPGX · Dual Track | Alere Scarborough, Inc. | 05/02/2018SE |
| K173398 | Xpert Xpress Strep APGX · Dual Track | Cepheid | 04/26/2018SE |
| K172402 | ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File KitPGX · Traditional | Luminex Corporation | 10/30/2017SE |
| K172126 | Xpert Xpress Strep APGX · Traditional | Cepheid | 09/25/2017SE |
| K162274 | Solana Strep Complete AssayPGX · Traditional | Quidel Corporation | 10/25/2016SE |
| K150868 | Solana GAS Assay, Solana instrumentPGX · Traditional | Quidel Corporation | 06/23/2015SE |
More from Quidel Corporation
Questions and answers
When was Liat Strep a Assay cleared by the FDA?
Liat Strep a Assay (K141338) received a 510(k) decision of Substantially Equivalent on November 4, 2014, 167 days after the submission was received.
What is the product code of K141338?
The FDA product code is PGX – Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System, a Class II (moderate risk) device regulated under 21 CFR 866.2680.